Higher co-pays, multi-tier formularies, cost-shifting to patients, and products moving to OTC are only a few of the managed care issues facing pharmaceutical companies. And with more than 75 percent of all prescriptions being paid for by third-party payors, managed care will continue to play a significant role in the U.S.
In response, IMS Managed Care offerings provide the business intelligence needed to grow market share through managed care plans. We provide clients with answers to critical strategic questions:
- How can I get my product on formulary?
- How can I grow market share within specific plans?
- How can I project adoption of a product during a launch?
Key business issues addressed through IMS Managed Care offerings include:
- Plan Strategy
- Plan Contract Management
- Plan Contract Tracking
- Formulary Assessment
- Physician Affiliation and Performance

|
|
 |

To learn more about how IMS can help your company, contact us.
For regional contact information, click here.
|
 |
|

|
email this page
print this page